+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • PDF Icon

    Report

  • 220 Pages
  • July 2023
  • Region: Asia Pacific
  • Renub Research
  • ID: 5562686
Asia Breast Cancer Screening Market is projected to reach US$ 275.6 Million by 2028, according to the publisher. Breast cancer stands as the prevailing cancer diagnosis among women and remains the primary cause of cancer-related fatalities in Asia. Breast cancer affects Asian women at an earlier age compared to their Western counterparts. In Asian countries, the peak age for breast cancer occurrence typically falls between 40 and 50 years, whereas in Western countries, it tends to be between 60 and 70 years. This disparity highlights the importance of considering regional and demographic factors when addressing breast cancer prevention, screening, and treatment strategies. Understanding these variations can help tailor healthcare approaches to effectively address the specific needs and challenges faced by different populations in combating breast cancer.

Asia Breast Cancer Screening Market is expected to grow at a CAGR of 4.15% from 2022 to 2028

Asia, the most populous and diverse continent, is home to approximately 4.75 billion people out of the world's total population of 8 billion. By 2050, the continent's population is expected to grow by an additional 1.8 billion individuals. This growth is a result of ongoing socioeconomic development and improved control of communicable diseases, leading to increased life expectancy across all Asian countries. As a consequence, the proportion of individuals aged 65 years and above is projected to double by 2030.

With cancer risk strongly linked to age, this demographic shift raises concerns about the escalating cancer burden and changing cancer patterns in Asian countries. Factors such as changing lifestyles, urbanization, reproductive patterns, dietary changes, obesity, tobacco use, alcohol consumption, chronic infections, and longer lifespans contribute to the rising cancer burden, particularly in low-resource and medium-resource countries in Asia.

Anticipated is the rise in awareness about breast cancer and promotion of optimal treatment through supportive measures by local governments and public organizations. Notably, Breast International Group (BIG) has partnered with the Breast Disease Professional Committee of CMEA (BDPCC) in China, the Korean Cancer Study Group (KCSG) in South Korea, and the Thai Society of Clinical Oncology (TSCO) in Thailand to facilitate research collaborations focused on breast cancer. These initiatives aim to enhance knowledge sharing and cooperation among experts, fostering advancements in breast cancer research and treatment for the benefit of patients in these regions. As a result, Asia Breast Cancer Screening Market was valued at US$ 216 Million in 2022.

With a focus on improving healthcare outcomes, China is poised to make significant strides in Asia breast cancer screening and prevention

By countries, Asia Breast Cancer Screening Market is breakup into India, China, Japan, Korea, Singapore, Thailand and Malaysia. The Breast Cancer Screening industry in China has witnessed significant growth and development. Factors such as increasing awareness about breast cancer, improving healthcare infrastructure, and rising government initiatives have contributed to this progress. The Chinese government has implemented screening programs and campaigns to promote early detection and treatment. Technological advancements have also played a crucial role, with the adoption of advanced imaging techniques like mammography and ultrasound. Moreover, collaborations between healthcare institutions, research organizations, and industry players have further propelled the growth of the Breast Cancer Screening industry in China.

With its rapid population growth trajectory, India is poised to make significant strides in the Asia Breast Cancer Mammography Screening industry

By Mammography Screening, Asia Breast Cancer Screening Market is segmented into China, India, Japan, Korea, Singapore, Thailand and Malaysia. India is emerging as the fastest-growing market in the Breast Cancer Mammography Screening industry. The country has witnessed a remarkable surge in breast cancer awareness and a growing emphasis on early detection. The Indian government, along with various healthcare organizations and NGOs, has implemented extensive screening programs and awareness campaigns across the nation.

Technological advancements in mammography imaging and increasing investments in healthcare infrastructure have further boosted the growth of the industry. With a rising population and changing lifestyles, the demand for breast cancer screening services in India is projected to continue its rapid expansion. India commitment to improving breast cancer diagnosis and treatment outcomes positions it as a key player in the global Breast Cancer Mammography Screening industry.

China is expected to witness a significant increase in its market presence in the Asia Breast Cancer MRI Screening industry

By MRI Screening, Asia Breast Cancer Screening Market is divided into China, Japan, India, Korea, Singapore, Thailand and Malaysia. China is poised to experience a surge in its market share within the Breast Cancer MRI Screening industry. The country expanding healthcare infrastructure, growing investments in advanced imaging technologies and increasing awareness about the importance of early breast cancer detection are driving this growth. The Chinese government has also implemented initiatives to improve access to breast cancer screening services, particularly in rural and underserved areas. Collaborations between domestic and international medical institutions, along with the involvement of leading industry players, are contributing to the development and adoption of state-of-the-art MRI screening technologies.

With its accelerating growth rate, China is poised to dominate the Asia Breast Cancer Ultrasound Screening industry

By Ultrasound Screening, Asia Breast Cancer Screening Market is classified into China, Japan, Korea, Singapore, India, Thailand and Malaysia. China is emerging as the fastest-growing market in the Breast Cancer Ultrasound Screening industry. The country's healthcare landscape has witnessed remarkable advancements in ultrasound technology, driving improved accuracy and efficiency in breast cancer diagnosis. Increasing awareness about the importance of early detection and screening has fueled the demand for ultrasound screening services in China. The government's initiatives to expand healthcare access, particularly in rural areas, have further contributed to the industry's rapid growth. Collaborations between healthcare providers, research institutions, and industry leaders have also played a significant role in fostering innovation and driving the adoption of advanced ultrasound screening solutions.

Key company

AstraZeneca, Hologic Corporation, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health are key players in the Breast Cancer Ultrasound Screening industry in Asia. These companies are at the forefront of developing and providing advanced ultrasound screening solutions for breast cancer detection and diagnosis.

This report titled “Asia Breast Cancer Screening Market by Type (Mammography Screening, MRI Screening, and Ultrasound Screening) by Country (China, India, Japan, Korea, Singapore, Thailand and Malaysia) by Company Analysis (AstraZeneca, Hologic Corporation, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health)” provides a complete analysis of Europe Breast Cancer Screening Industry.

Types - Market has been covered from 3 viewpoints

1. Mammography Screening
2. MRI Screening
3. Ultrasound Screening

Countries - 7 Asian Country Breast Cancer Screening Market has been Covered

1. China
2. India
3. Japan
4. Korea
5. Singapore
6. Thailand
7. Malaysia

Company Insights:

  • Overview
  • Recent Development
  • Sales Analysis

Companies Covered in the Report:

1. AstraZeneca
2. Hologic Corporation
3. Becton
4. Siemens AG
5. Roche Diagnostics
6. Quest Diagnostics
7. Cardinal Health

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Porter’s Five Forces
5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products
6. SWOT Analysis
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats
7. Asia Pacific Breast Cancer Screening Analysis
7.1 Asia Pacific Breast Cancer Market
7.2 Asia Pacific Breast Cancer Population
8. Asia Breast Cancer Screening Population Analysis
8.1 Mammography Screening Population
8.2 MRI & Ultrasound Screening Population
9. Asia Breast Cancer Screening Market Analysis
9.1 Breast Cancer Screening Market
9.1.1 Mammography Screening Market
9.1.2 MRI Screening Market
9.1.3 Ultrasound Screening Market
10. Asia Breast Cancer Screening Population & Market Share Analysis
10.1 Mammography Screening Population Share
10.2 MRI & Ultrasound Screening Population Share
11. Asia Breast Cancer Screening Market Share Analysis
11.1 Asia Breast Cancer Screening Market Share
11.2 Mammography Screening Market Share
11.3 MRI Screening Market Share
11.4 Ultrasound Screening Market Share
12. India
12.1 India Breast Cancer Mammography Screening Population
12.2 India Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
12.3 India Breast Cancer Screening Market
12.3.1 Mammography Screening Market
12.3.2 Magnetic Resonance Imaging (MRI) Screening Market
12.3.3 Ultrasound Screening Market
13. China
13.1 China Breast Cancer Mammography Screening Population
13.2 China Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
13.3 China Breast Cancer Screening Market & Forecast
13.3.1 Mammography Screening Market
13.3.2 Magnetic Resonance Imaging (MRI) Screening Market
13.3.3 Ultrasound Screening Market
14. Japan
14.1 Japan Breast Cancer Mammography Screening Population
14.2 Japan Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
14.3 Japan Breast Cancer Screening Market
14.3.1 Mammography Screening Market
14.3.2 Magnetic Resonance Imaging (MRI) Screening Market
14.3.3 Ultrasound Screening Market
15. Korea
15.1 Korea Breast Cancer Mammography Screening Population
15.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
15.3 Korea Breast Cancer Screening Market
15.3.1 Mammography Screening Market
15.3.2 Magnetic Resonance Imaging (MRI) Screening Market
15.3.3 Ultrasound Screening Market
16. Singapore
16.1 Singapore Breast Cancer Mammography Screening Population
16.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
16.3 Singapore Breast Cancer Screening Market
16.3.1 Mammography Screening Market
16.3.2 Magnetic Resonance Imaging (MRI) Screening Market
16.3.3 Ultrasound Screening Market
17. Thailand
17.1 Thailand Breast Cancer Mammography Screening Population
17.2 Thailand Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
17.3 Thailand Breast Cancer Screening Market
17.3.1 Mammography Screening Market
17.3.2 Magnetic Resonance Imaging (MRI) Screening Market
17.3.3 Ultrasound Screening Market
18. Malaysia
18.1 Malaysia Breast Cancer Mammography Screening Population
18.2 Malaysia Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
18.3 Malaysia Breast Cancer Screening Market
18.3.1 Mammography Screening Market
18.3.2 Magnetic Resonance Imaging (MRI) Screening Market
18.3.3 Malaysia Breast Cancer Ultrasound Screening Market
19. Company Analysis
19.1 AstraZeneca
19.1.1 Overview
19.1.2 Recent Development
19.1.3 Revenue
19.2 Hologic Corporation
19.2.1 Overview
19.2.2 Recent Development
19.2.3 Revenue
19.3 Becton
19.3.1 Overview
19.3.2 Recent Development
19.3.3 Revenue
19.4 Siemens AG
19.4.1 Overview
19.4.2 Recent Development
19.4.3 Revenue
19.5 Roche Diagnostics
19.5.1 Overview
19.5.2 Recent Development
19.5.3 Revenue
19.6 Quest Diagnostics
19.6.1 Overview
19.6.2 Recent Development
19.6.3 Revenue
19.7 Cardinal Health
19.7.1 Overview
19.7.2 Recent Development
19.7.3 Revenue
List of Figures:
Figure-01: Asia - Breast Cancer Screening Market (Million US$), 2018 - 2022
Figure-02: Asia - Forecast for Breast Cancer Screening Market (Million US$), 2023 - 2028
Figure-03: Asia - Breast Cancer Screening Population (Million), 2018 - 2022
Figure-04: Asia - Forecast for Breast Cancer Screening Population (Million), 2023 - 2028
Figure-05: Asia - Breast Cancer Mammography Screening Population (Million), 2018 - 2022
Figure-06: Asia - Forecast for Breast Cancer Mammography Screening Population (Million), 2023 - 2028
Figure-07: Asia - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-08: Asia - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-09: Asia - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-10: Asia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-11: Asia - Breast Cancer MRI Screening Market (Million US$), 2018 - 2022
Figure-12: Asia - Forecast for Breast Cancer MRI Screening Market (Million US$), 2023 - 2028
Figure-13: Asia - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-14: Asia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-15: India - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-16: India - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-17: India - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-18: India - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-19: India - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-20: India - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-21: India - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-22: India - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-23: India - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-24: India - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-25: China - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-26: China - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-27: China - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-28: China - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-29: China - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-30: China - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-31: China - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-32: China - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-33: China - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-34: China - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-35: Japan - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-36: Japan - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-37: Japan - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-38: Japan - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-39: Japan - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-40: Japan - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-41: Japan - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-42: Japan - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-43: Japan - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-44: Japan - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-45: Korea - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-46: Korea - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-47: Korea - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-48: Korea - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-49: Korea - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-50: Korea - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-51: Korea - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-52: Korea - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-53: Korea - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-54: Korea - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-55: Singapore - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-56: Singapore - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-57: Singapore - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-58: Singapore - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-59: Singapore - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-60: Singapore - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-61: Singapore - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-62: Singapore - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-63: Singapore - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-64: Singapore - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-65: Thailand - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-66: Thailand - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-67: Thailand - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-68: Thailand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-69: Thailand - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-70: Thailand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-71: Thailand - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-72: Thailand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-73: Thailand - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-74: Thailand - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-75: Malaysia - Breast Cancer Mammography Screening Population (Thousand), 2018 - 2022
Figure-76: Malaysia - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2023 - 2028
Figure-77: Malaysia - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2018 - 2022
Figure-78: Malaysia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2023 - 2028
Figure-79: Malaysia - Breast Cancer Mammography Screening Market (Million US$), 2018 - 2022
Figure-80: Malaysia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 - 2028
Figure-81: Malaysia - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 - 2022
Figure-82: Malaysia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 - 2028
Figure-83: Malaysia - Breast Cancer Ultrasound Screening Market (Million US$), 2018 - 2022
Figure-84: Malaysia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 - 2028
Figure-85: AstraZeneca - Global Revenue (Million US$), 2018 - 2022
Figure-86: AstraZeneca - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-87: Hologic Corporation - Global Revenue (Million US$), 2018 - 2022
Figure-88: Hologic Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-89: Becton - Global Revenue (Million US$), 2018 - 2022
Figure-90: Becton - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-91: Siemens AG - Global Revenue (Million US$), 2018 - 2022
Figure-92: Siemens AG - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-93: Roche Diagnostics - Global Revenue (Million US$), 2018 - 2022
Figure-94: Roche Diagnostics - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-95: Quest Diagnostics - Global Revenue (Million US$), 2018 - 2022
Figure-96: Quest Diagnostics - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure-97: Cardinal Health - Global Revenue (Million US$), 2018 - 2022
Figure-98: Cardinal Health - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table-01: Asia - Mammography Screening Population Share by Country (Percent), 2018 - 2022
Table-02: Asia - Forecast for Mammography Screening Population Share by Country (Percent), 2023 - 2028
Table-03: Asia - MRI & Ultrasound Screening Population Share by Country (Percent), 2018 - 2022
Table-04: Asia - Forecast for MRI & Ultrasound Screening Population Share by Country (Percent), 2023 - 2028
Table-05: Asia - Breast Cancer Screening Market Share by Country (Percent), 2018 - 2022
Table-06: Asia - Forecast for Breast Cancer Screening Market Share by Country (Percent), 2023 - 2028
Table-07: Asia - Mammography Screening Market Share by Country (Percent), 2018 - 2022
Table-08: Asia - Forecast for Mammography Screening Market Share by Country (Percent), 2023 - 2028
Table-09: Asia - MRI Screening Market Share by Country (Percent), 2018 - 2022
Table-10: Asia - Forecast for MRI Screening Market Share by Country (Percent), 2023 - 2028
Table-11: Asia - Ultrasound Screening Market Share by Country (Percent), 2018 - 2022
Table-12: Asia - Forecast for Ultrasound Screening Market Share by Country (Percent), 2023 - 2028

Companies Mentioned

  • AstraZeneca
  • Hologic Corporation
  • Becton
  • Siemens AG
  • Roche Diagnostics
  • Quest Diagnostics
  • Cardinal Health

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information